Cronos Group (CRON)

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Will big US pharma swamp big Canadian pot growers?

As we wrote in an INK Research subscriber post on February 12th, the widespread belief that the cannabis industry is a disruptive force in the medical and consumer markets may well be in the process of playing out right now. The stakes are clearly high, especially if John Rubino from DollarCollapse.com is right.

 Rubino: the pot legalization tide has turned in the United States.

He is firmly in the camp with those who think legalization is not that far off in the United States:

Subscribe to RSS - Cronos Group (CRON)